Yesterday, Nov. 10, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $354.40 to $12,639,826.44.

Highlighted Stocks Traded by Insiders:

Aratana Therapeutics (PETX) - FREE Research Report

Tooman Craig A, who is Chief Financial Officer at Aratana Therapeutics, sold 3,620 shares at $7.52 on Nov. 10, 2015. Following this transaction, the Chief Financial Officer owned 69,980 shares meaning that the stake was reduced by 4.92% with the 3,620-share transaction.

The shares most recently traded at $7.12, down $0.40, or 5.68% since the insider transaction. Historical insider transactions for Aratana Therapeutics go as follows:

  • 4-Week # shares sold: 3,250
  • 12-Week # shares sold: 3,250
  • 24-Week # shares bought: 10,333
  • 24-Week # shares sold: 18,250

The average volume for Aratana Therapeutics has been 521,700 shares per day over the past 30 days. Aratana Therapeutics has a market cap of $265.4 million and is part of the health care sector and drugs industry. Shares are down 62.18% year-to-date as of the close of trading on Tuesday.

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. Currently, there are 7 analysts who rate Aratana Therapeutics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PETX - FREE

TheStreet Quant Ratings rates Aratana Therapeutics as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Aratana Therapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Palo Alto Networks (PANW) - FREE Research Report

Zuk Nir, who is Cto at Palo Alto Networks, sold 30,000 shares at $160.45 on Nov. 10, 2015. Following this transaction, the Cto owned 2.1 million shares meaning that the stake was reduced by 1.44% with the 30,000-share transaction.

The shares most recently traded at $157.60, down $2.85, or 1.81% since the insider transaction. Historical insider transactions for Palo Alto Networks go as follows:

  • 4-Week # shares sold: 685
  • 12-Week # shares sold: 99,851
  • 24-Week # shares sold: 222,917

The average volume for Palo Alto Networks has been 1.7 million shares per day over the past 30 days. Palo Alto Networks has a market cap of $13.8 billion and is part of the technology sector and computer hardware industry. Shares are up 28.33% year-to-date as of the close of trading on Tuesday.

Palo Alto Networks, Inc. provides enterprise security platform to enterprises, service providers, and government entities worldwide. Currently, there are 20 analysts who rate Palo Alto Networks a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PANW - FREE

TheStreet Quant Ratings rates Palo Alto Networks as a sell. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full Palo Alto Networks Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

OFG Bancorp (OFG) - FREE Research Report

Pena Radames, who is Director at OFG Bancorp, sold 2,396 shares at $19.97 on Nov. 10, 2015. Following this transaction, the Director owned 1,330 shares meaning that the stake was reduced by 64.3% with the 2,396-share transaction.

The shares most recently traded at $9.98, down $9.99, or 100.1% since the insider transaction. Historical insider transactions for OFG Bancorp go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 6,829
  • 12-Week # shares bought: 8,100
  • 12-Week # shares sold: 6,829
  • 24-Week # shares bought: 8,100
  • 24-Week # shares sold: 31,829

The average volume for OFG Bancorp has been 721,600 shares per day over the past 30 days. OFG Bancorp has a market cap of $452.7 million and is part of the financial sector and banking industry. Shares are down 39.94% year-to-date as of the close of trading on Tuesday.

OFG Bancorp, a financial holding company, provides various banking and financial services primarily in Puerto Rico. It operates in three segments: Banking, Wealth Management, and Treasury. The stock currently has a dividend yield of 3.88%. The company has a P/E ratio of 114.7. Currently, there are 2 analysts who rate OFG Bancorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on OFG - FREE

TheStreet Quant Ratings rates OFG Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income. Get the full OFG Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.